These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 22184406)
1. Mouse NK cell-mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing. Sun K; Alvarez M; Ames E; Barao I; Chen M; Longo DL; Redelman D; Murphy WJ Blood; 2012 Feb; 119(6):1590-8. PubMed ID: 22184406 [TBL] [Abstract][Full Text] [Related]
2. Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens. Raziuddin A; Longo DL; Bennett M; Winkler-Pickett R; Ortaldo JR; Murphy WJ Blood; 2002 Oct; 100(8):3026-33. PubMed ID: 12351417 [TBL] [Abstract][Full Text] [Related]
3. Contrasting effects of anti-Ly49A due to MHC class I cis binding on NK cell-mediated allogeneic bone marrow cell resistance. Alvarez M; Sungur CM; Ames E; Anderson SK; Pomeroy C; Murphy WJ J Immunol; 2013 Jul; 191(2):688-98. PubMed ID: 23752612 [TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2(b) bone marrow cell allografts. Raziuddin A; Bennett M; Winkler-Pickett R; Ortaldo JR; Longo DL; Murphy WJ Blood; 2000 Jun; 95(12):3840-4. PubMed ID: 10845918 [TBL] [Abstract][Full Text] [Related]
5. Ly49I NK cell receptor transgene inhibition of rejection of H2b mouse bone marrow transplants. Liu J; Morris MA; Nguyen P; George TC; Koulich E; Lai WC; Schatzle JD; Kumar V; Bennett M J Immunol; 2000 Feb; 164(4):1793-9. PubMed ID: 10657626 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets. Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959 [TBL] [Abstract][Full Text] [Related]
7. Regulation of the NK cell alloreactivity to bone marrow cells by the combination of the host NK gene complex and MHC haplotypes. Iizuka K; Scalzo AA; Xian H; Yokoyama WM J Immunol; 2008 Mar; 180(5):3260-7. PubMed ID: 18292550 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules. Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631 [TBL] [Abstract][Full Text] [Related]
9. Ly49-dependent NK cell licensing and effector inhibition involve the same interaction site on MHC ligands. Choi T; Ferris ST; Matsumoto N; Poursine-Laurent J; Yokoyama WM J Immunol; 2011 Apr; 186(7):3911-7. PubMed ID: 21335486 [TBL] [Abstract][Full Text] [Related]
10. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells. George TC; Mason LH; Ortaldo JR; Kumar V; Bennett M J Immunol; 1999 Feb; 162(4):2035-43. PubMed ID: 9973475 [TBL] [Abstract][Full Text] [Related]
11. MHC class I recognition by NK receptors in the Ly49 family is strongly influenced by the beta 2-microglobulin subunit. Michaëlsson J; Achour A; Rölle A; Kärre K J Immunol; 2001 Jun; 166(12):7327-34. PubMed ID: 11390483 [TBL] [Abstract][Full Text] [Related]
12. Role of classical (RT1.A) and nonclassical (RT1.C) MHC class I regions in natural killer cell-mediated bone marrow allograft rejection in rats. Engh E; Benestad HB; Strøm-Gundersen I; Vaage JT; Bell EB; Rolstad B Transplantation; 1998 Feb; 65(3):319-24. PubMed ID: 9484746 [TBL] [Abstract][Full Text] [Related]
13. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection. Held W; Cado D; Raulet DH J Exp Med; 1996 Nov; 184(5):2037-41. PubMed ID: 8920892 [TBL] [Abstract][Full Text] [Related]
14. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts. Taylor MA; Ward B; Schatzle JD; Bennett M Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623 [TBL] [Abstract][Full Text] [Related]
15. Altered donor and recipient Ly49+ NK cell subsets in allogeneic H-2d --> H-2b and H-2b --> H-2d bone marrow chimeras. Korten S; Wilk E; Gessner JE; Meyer D; Schmidt RE J Immunol; 1999 Dec; 163(11):5896-905. PubMed ID: 10570275 [TBL] [Abstract][Full Text] [Related]
16. NK cell tolerance in mixed allogeneic chimeras. Zhao Y; Ohdan H; Manilay JO; Sykes M J Immunol; 2003 Jun; 170(11):5398-405. PubMed ID: 12759414 [TBL] [Abstract][Full Text] [Related]
17. The immunobiology of natural killer cells and bone marrow allograft rejection. Barao I; Murphy WJ Biol Blood Marrow Transplant; 2003 Dec; 9(12):727-41. PubMed ID: 14677112 [TBL] [Abstract][Full Text] [Related]
18. Class I MHC-binding characteristics of the 129/J Ly49 repertoire. Makrigiannis AP; Pau AT; Saleh A; Winkler-Pickett R; Ortaldo JR; Anderson SK J Immunol; 2001 Apr; 166(8):5034-43. PubMed ID: 11290784 [TBL] [Abstract][Full Text] [Related]
19. The activating Ly49W and inhibitory Ly49G NK cell receptors display similar affinities for identical MHC class I ligands. Ma BJ; Craveiro Salvado CM; Kane KP Immunogenetics; 2014 Aug; 66(7-8):467-77. PubMed ID: 24797174 [TBL] [Abstract][Full Text] [Related]
20. Ly-49 G2+ NK cells are responsible for mediating the rejection of H-2b bone marrow allografts in mice. Raziuddin A; Longo DL; Mason L; Ortaldo JR; Murphy WJ Int Immunol; 1996 Dec; 8(12):1833-9. PubMed ID: 8982767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]